Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Journal of the American Academy of Dermatology|October 19, 2001
Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literatureR W Plunkett, S E Chiarello, E H Beutner
Biochemical Pharmacology|January 1, 1979
Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivoW Plunkett, L Alexander, S Chubb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion scheduleJ F Seymour, P Huang, W Plunkett, et al.
Leukemia & Lymphoma|May 1, 1993
Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapyV Gandhi, A Kemena, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapyV Gandhi, E Estey, M J Keating, et al.
The Journal of Manual & Manipulative Therapy|September 23, 2009
Comparison of manual therapy techniques with therapeutic exercise in the treatment of shoulder impingement: a randomized controlled pilot clinical trialAimie F Kachingwe, Beth Phillips, Eric Sletten, et al.
Leukemia & Lymphoma|October 1, 1996
Why do drugs work in CLL?W Plunkett, A Begleiter, J O Liliemark, et al.
Molecular Pharmacology|May 1, 1995
Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repairL Y Yang, L Li, M J Keating, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1974
Penetration of mouse fibroblasts by the 5'-phosphate of 9-beta-D-arabinofuranosyladenine and incorporation of the nucleotide into DNAW Plunkett, L Lapi, P J Ortiz, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Journal of the American Academy of Dermatology|October 19, 2001
Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literatureR W Plunkett, S E Chiarello, E H Beutner
Biochemical Pharmacology|January 1, 1979
Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivoW Plunkett, L Alexander, S Chubb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion scheduleJ F Seymour, P Huang, W Plunkett, et al.
Leukemia & Lymphoma|May 1, 1993
Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapyV Gandhi, A Kemena, M J Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapyV Gandhi, E Estey, M J Keating, et al.
The Journal of Manual & Manipulative Therapy|September 23, 2009
Comparison of manual therapy techniques with therapeutic exercise in the treatment of shoulder impingement: a randomized controlled pilot clinical trialAimie F Kachingwe, Beth Phillips, Eric Sletten, et al.
Leukemia & Lymphoma|October 1, 1996
Why do drugs work in CLL?W Plunkett, A Begleiter, J O Liliemark, et al.
Molecular Pharmacology|May 1, 1995
Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repairL Y Yang, L Li, M J Keating, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1974
Penetration of mouse fibroblasts by the 5'-phosphate of 9-beta-D-arabinofuranosyladenine and incorporation of the nucleotide into DNAW Plunkett, L Lapi, P J Ortiz, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Pageof 25